Liquidia (NASDAQ:LQDA) Director Katherine Rielly-Gauvin Sells 18,393 Shares of Stock

Liquidia Corporation (NASDAQ:LQDA) Director Katherine Rielly-Gauvin sold 18,393 shares of the business’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $72.23, for a total transaction of $1,328,526.39. Following the sale, the director owned 44,637 shares of the company’s stock, valued at approximately $3,224,130.51. This represents a 29.18% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Katherine Rielly-Gauvin also recently made the following trade(s):

• On Wednesday, August 19th, Katherine Rielly-Gauvin sold 36,789 shares of Liquidia stock. The stock was sold at an average price of $74.99, for a total value of $2,758,807.11.

Liquidia Stock Performance

Shares of LQDA opened at $68.62 on Friday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.31 and a quick ratio of 2.12. Liquidia Corporation has a one year low of $21.15 and a one year high of $93.61. The firm has a market capitalization of $6.14 billion, a P/E ratio of 50.09 and a beta of 0.58. The business has a fifty day moving average of $79.29 and a 200 day moving average of $56.21.

Liquidia (NASDAQ:LQDA) last posted its earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). The firm had revenue of $171.68 million during the quarter, compared to the consensus estimate of $168.48 million. Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The firm’s revenue was up 1842.1% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.49) EPS. As a group, sell-side analysts anticipate that Liquidia Corporation will post 2.57 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts recently issued reports on LQDA shares. Jefferies Financial Group reissued a “buy” rating and issued a $60.00 price objective on shares of Liquidia in a report on Monday, May 11th. Raymond James Financial reiterated a “strong-buy” rating and issued a $106.00 price target on shares of Liquidia in a research report on Thursday, August 13th. Piper Sandler set a $129.00 price objective on shares of Liquidia in a research report on Friday, July 24th. Lifesci Capital lowered Liquidia from an “outperform” rating to a “hold” rating and set a $90.00 price objective for the company. in a research note on Wednesday, August 12th. Finally, Wall Street Zen cut Liquidia from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 27th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, three have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Liquidia has a consensus rating of “Hold” and a consensus price target of $98.08.

Hedge Funds Weigh In On Liquidia

Several institutional investors have recently bought and sold shares of the stock. Farallon Capital Management LLC lifted its stake in Liquidia by 1.1% in the 4th quarter. Farallon Capital Management LLC now owns 8,656,038 shares of the company’s stock worth $298,547,000 after purchasing an additional 90,400 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Liquidia by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 4,013,888 shares of the company’s stock valued at $138,439,000 after purchasing an additional 52,671 shares in the last quarter. Opaleye Management Inc. increased its holdings in shares of Liquidia by 9.5% in the second quarter. Opaleye Management Inc. now owns 2,475,000 shares of the company’s stock worth $30,838,000 after purchasing an additional 215,000 shares during the last quarter. Bank of America Corp DE increased its holdings in shares of Liquidia by 18.7% in the first quarter. Bank of America Corp DE now owns 2,287,792 shares of the company’s stock worth $86,341,000 after purchasing an additional 360,372 shares during the last quarter. Finally, TCG Crossover Management LLC purchased a new stake in shares of Liquidia during the 3rd quarter worth approximately $38,887,000. 64.54% of the stock is owned by hedge funds and other institutional investors.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).